Page last updated: 2024-10-29

iotrolan and Acute Edematous Pancreatitis

iotrolan has been researched along with Acute Edematous Pancreatitis in 1 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Post-ERCP pancreatitis was diagnosed in 2 patients in the iopromid group and in 5 patients in the iotrolan group."6.69Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial. ( Doppl, W; Goebel, C; Hackstein, N; Hardt, P; Klör, HU; Temme, H, 2000)
"Post-ERCP pancreatitis was diagnosed in 2 patients in the iopromid group and in 5 patients in the iotrolan group."2.69Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial. ( Doppl, W; Goebel, C; Hackstein, N; Hardt, P; Klör, HU; Temme, H, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goebel, C1
Hardt, P1
Doppl, W1
Temme, H1
Hackstein, N1
Klör, HU1

Trials

1 trial available for iotrolan and Acute Edematous Pancreatitis

ArticleYear
Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial.
    European radiology, 2000, Volume: 10, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Dou

2000